Huaihe Hospital of Henan University
7
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
29%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Role: collaborator
Clip-assisted Fixation to Prevent Migration of Fully Covered Self-expandable Metal Stent in Patients Undergoing ERCP
Role: collaborator
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Role: collaborator
Effect of Anatomy of Major Duodenal Papilla on the Difficulty of Cannulation During Endoscopic Retrograde Cholangiopancreatography
Role: collaborator
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
Role: collaborator
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
Role: collaborator
All 7 trials loaded